Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002872470 | SCV003239119 | uncertain significance | Charcot-Marie-Tooth disease, type I | 2022-10-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant, c.426_431del, results in the deletion of 2 amino acid(s) of the MPZ protein (p.Thr143_Leu144del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MPZ-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts a region of the MPZ protein in which other variant(s) (p.Thr143Met) have been observed in individuals with MPZ-related conditions (PMID: 20456450). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. |